583 Safety of peginterferon α-2a (40KD) (PEGASYS®) [PEG-IFNα-2a (40KD)] plus ribavirin (COPEGUS®) among pegylated interferon α-2b (12KD)/ribavirin non-responders: Interim analysis of the repeat study
暂无分享,去创建一个
M. Diago | F. Andreone | Y. Horsmans | Y. Benhamou | D. Jensen | F. Marcellin | G. Teuber | D. Rincon | A. Martins